Rs4968309 in Myosin Light Chain 4 (MYL4) Associated With Atrial Fibrillation Onset and Predicts Clinical Outcomes After Catheter Ablation in Atrial Fibrillation Patients Without Structural Heart Disease
- 25 September 2019
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 83 (10) , 1994-2001
Abstract
Background: Atrial fibrillation (AF) is the most common arrhythmia with serious complications and a high rate of recurrence after catheter ablation. Recently, mutation of MYL4 was reported as responsible for familial atrial cardiomyopathy and AF. This study aimed to determine the association between polymorphism in MYL4 with the onset and recurrence of AF. Methods and Results: A total of 7 single-nucleotide polymorphisms were selected by linkage disequilibrium and genotyped in 510 consecutive AF patients and 192 controls without structural heart disease. A total of 246 AF patients who underwent cryoballoon ablation had a 1-year scheduled follow-up study for AF recurrence. C allele and CC genotype of rs4968309 and A allele of rsl 515751 were associated with AF onset both before and after adjustment of covariation (age, sex, hypertension, and diabetes). AF type and left atrial size were different among the genotypes of rs4968309. Moreover, CC genotype of rs4968309 increased susceptibly of AF recurrence after cryoballoon ablation. The prevalence of hypertension was associated with rsl 515752, and left atrial size was associated with the genotype of rs2071438. Conclusions: C allele and CC genotype of rs4968309 in MYL4 were associated with AF onset and recurrence. Moreover, the A allele of rs1515751 had a significant association with AF onset. The polymorphisms of MYL4 can predict AF onset and prognosis after ablation in AF patients without structural heart disease.Keywords
This publication has 27 references indexed in Scilit:
- A randomised comparison of Cartomerge vs. NavX fusion in the catheter ablation of atrial fibrillation: The CAVERN TrialJournal of Interventional Cardiac Electrophysiology, 2011
- Recent advances in the molecular pathophysiology of atrial fibrillationJournal of Clinical Investigation, 2011
- Safety and Efficacy of the Oral Direct Factor Xa Inhibitor Apixaban in Japanese Patients With Non-Valvular Atrial FibrillationCirculation Journal, 2011
- The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implicationsCardiovascular Research, 2010
- Paradigm of Genetic Mosaicism and Lone Atrial FibrillationCirculation, 2010
- Genetics of familial atrial fibrillationEP Europace, 2009
- The Role of the N-Terminus of the Myosin Essential Light Chain in Cardiac Muscle ContractionJournal of Molecular Biology, 2009
- Atrial Natriuretic Peptide Frameshift Mutation in Familial Atrial FibrillationNew England Journal of Medicine, 2008
- Myosin essential light chain in health and diseaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- The G Protein–Gated Potassium CurrentIK,AChIs Constitutively Active in Patients With Chronic Atrial FibrillationCirculation, 2005